Prevalence of MASLD and Fibrosis Risk in Turkish Adults with Cardiometabolic Risk Factors: A Nationwide Multicenter Study (DAHUDER MASLD Study)
Journal of Clinical Medicine · 08.10.2025 · 14 (19) · 7098
DOI: 10.3390/jcm14197098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 08.10.2025. Verfasst von Ali Kirik und 59 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Balikesir University Medical School, Balikesir 10145, Türkiye. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Recep Tayyip Erdoğan University Development Foundation.
Abstract (Originalsprache)
Introduction
Metabolic dysfunction-associated steatotic liver disease (MASLD) prevalence data in Türkiye is limited. We aimed to determine the nationwide prevalence of MASLD and advanced hepatic fibrosis risk in subjects with cardiometabolic risk factors (CMRF). Despite recent international consensus redefining fatty liver disease terminology, no nationwide MASLD study has been reported in Türkiye.
Methods
This cross-sectional study included 14,371 adults with ≥1 CMRF from 44 centers across 31 cities. MASLD was diagnosed using liver ultrasonography plus cardiometabolic criteria. Advanced fibrosis risk was assessed by fibrosis-4 (FIB-4) score (≥1.3 for ≤65 years; ≥2.0 for >65 years). Logistic regression was used to identify independent predictors of high FIB-4.
Results
A total of 61.4% of participants were women, the mean age was 51.3 ± 14.4 years, and the mean BMI was 31.4 ± 6.0 kg/m2. MASLD prevalence was 75.7% (n = 10,873), rising with the number of CMRFs (56.5% with one factor vs. 83.4% with all). The prevalence of high FIB-4 scores was 12.0% overall, being lower in MASLD patients than non-MASLD patients (11.2% vs. 14.4%, p < 0.001). FIB-4 scores decreased with increasing BMI (28.1% underweight vs. 8.7% class III obesity). Male sex, T2DM, and hypertension independently predicted high FIB-4 scores, while smoking, higher BMI, and MASLD were inversely associated.
Conclusions
Three-quarters of Turkish adults with CMRF have MASLD. Standard FIB-4 thresholds may underestimate fibrosis risk in obese and smoking populations, underscoring the need for adjusted cut-offs or alternative tools. This study is the first to provide nationwide MASLD prevalence data in Türkiye.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Balikesir University Medical School, Balikesir 10145, Türkiye.
- Department of Internal Medicine, Adana Health Practice and Research Center, University of Health Sciences, Adana 01230, Türkiye.
- Department of Internal Medicine, Bursa City Hospital, Bursa 16250, Türkiye.
- Department of Internal Medicine, Kütahya Health Sciences University, Kütahya 43020, Türkiye.
- Department of Internal Medicine, Izmir City Hospital, İzmir 35540, Türkiye.
- Department of Internal Medicine, Çorlu Vatan Hospital, Tekirdag 59850, Türkiye.
ORCID-Profile: Ali Kirik, Hilmi Erdem Sumbul, Nizameddin Koca, Emine Binnetoglu, Eşref Araç, Canan Akkuş, Berrin Aksakal, Gulali Aktas, Burçin Meryem Atak Tel, Ahmet Aydın, Sami Bahçebaşı, Orhan Balıkçı, Lale Saka Baraz, Bilgin Bahadır Başgöz, Muharrem Bayrak, Hilal Bektaş Uysal, Rıfat Bozkuş, Fatih Coşkun, Deniz Cekiç, Betül Erişmiş, Müzeyyen Eryılmaz, Ahmed Bilal Genç, Fatih İleri, Kubilay İşsever, Özge Kama Başcı, İsmail Kırlı, Yusuf Kimyon, Kamil Konur, Özge Kurtkulağı, Celalettin Küçük
Förderung
- Recep Tayyip Erdoğan University Development Foundation
Zitieren
APA
Kirik, A., Sumbul, H. E., Koca, N., Paşalı Kilit, T., Demiral Sezer, S., Binnetoglu, E., Araç, E., Solmaz, İ., Şen, H., Demirci, İ., Abaylı, B., Akan, H., Akkuş, C., Aksakal, B., Aktas, G., Alakuş, Ö. F., Atak Tel, B. M., Aydın, A., Bahçebaşı, S., …, & Mamiş, M. S. (2025). Prevalence of MASLD and Fibrosis Risk in Turkish Adults with Cardiometabolic Risk Factors: A Nationwide Multicenter Study (DAHUDER MASLD Study). Journal of Clinical Medicine, 14(19), 7098. https://doi.org/10.3390/jcm14197098
Vancouver
Kirik A, Sumbul HE, Koca N, Paşalı Kilit T, Demiral Sezer S, Binnetoglu E, et al. Prevalence of MASLD and Fibrosis Risk in Turkish Adults with Cardiometabolic Risk Factors: A Nationwide Multicenter Study (DAHUDER MASLD Study). Journal of Clinical Medicine. 2025;14(19):7098. doi:10.3390/jcm14197098
BibTeX
@article{Kirik2025,
author = {Kirik, Ali and Sumbul, Hilmi Erdem and Koca, Nizameddin and Paşalı Kilit, Türkan and Demiral Sezer, Sibel and Binnetoglu, Emine and Araç, Eşref and Solmaz, İhsan and Şen, Hacer and Demirci, İbrahim and Abaylı, Bahri and Akan, Hale and Akkuş, Canan and Aksakal, Berrin and Aktas, Gulali and Alakuş, Ömer Faruk and Atak Tel, Burçin Meryem and Aydın, Ahmet and Bahçebaşı, Sami and Balıkçı, Orhan and Saka Baraz, Lale and Başgöz, Bilgin Bahadır and Bayrak, Muharrem and Bektaş Uysal, Hilal and Beyazal Polat, Hatice and Biçer, İfakat İrem and Bozkuş, Rıfat and Coşkun, Fatih and Çağatay, Cüneyt and Çağlar, Feride and Çakmak, Erkan and Cekiç, Deniz and Değer, Ülfet and Demir, Ayse Kevser and Demir, İsmail and Dizdar, Oğuzhan Sıtkı and Dulkadiroğlu, Erkan and Düzen Oflas, Nur and Erişmiş, Betül and Erol, Ali and Ertınmaz, Ayşegül and Eryılmaz, Müzeyyen and Gemcioğlu, Emin and Genç, Ahmed Bilal and Gökgöz, Melis and Gözel, Nevzat and İleri, Fatih and İşsever, Kubilay and İzlimek, Uğur Can and Kama Başcı, Özge and Kamburoğlu, Aynur and Kamış, Fatih and Kayhan, Sanem and Kırlı, İsmail and Kimyon, Yusuf and Kocaman, Şeref Enes and Konur, Kamil and Kurtkulağı, Özge and Küçük, Celalettin and Mamiş, Mehmet Selim},
title = {Prevalence of MASLD and Fibrosis Risk in Turkish Adults with Cardiometabolic Risk Factors: A Nationwide Multicenter Study (DAHUDER MASLD Study)},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {19},
pages = {7098},
doi = {10.3390/jcm14197098}
}
EUVIMED